Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down 0.10% Nasdaq Up 0.23%
Streaming
Ticker Tape: On

ImmunoCellular Therapeutics, Ltd. (IMUC)

-NYSE MKT
1.19 Up 0.03(2.59%) Apr 17, 4:00PM EDT
Get the big picture on all your investments.
Prev Close:1.16
Open:1.17
Bid:1.00 x 300
Ask:1.25 x 200
1y Target Est:5.69
Beta:0.91
Earnings Date:May 5 - May 15 (Est.)
Day's Range:1.14 - 1.20
52wk Range:0.65 - 4.00
Volume:505,740
Avg Vol (3m):2,067,690
Market Cap:68.50M
P/E (ttm):N/A
EPS (ttm):-0.16
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for IMUC

Comparison

Symbol% ChgMkt Cap
IMUCUp 2.59%68.50M
AGENUp 5.81%158.54M
DNDNDown 1.49%406.39M
STMLDown 0.76%201.74M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.25
Quarterly EPS Est (Mar-14) :-0.04
Mean Recommendation*:2.3
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ImmunoCellular Therapeutics, Ltd., a clinical-stage biotechnology company, develops immune-based therapies for the treatment of brain and ovarian cancers. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback